An innovative biopharmaceutical medicine from China has been approved by the US Food and Drug Administration (FDA) to treat cancer ... which allows the immune system to activate and kill tumours.
Innovative cancer medicine toripalimab has become the first biopharmaceutical drug from China ... FDA turned to manufacturers outside the US, including Chinese company Qilu Pharmaceutical, to ...
In 2018, Hutchmed’s fruquintinib became the first domestically developed drug for a major cancer type to be approved in China. Five years later, the FDA has ... which will allow you to be ...
Cancer drugs, in particular, are in such short supply that the FDA has temporarily authorized the medical industry to import non-FDA-approved drugs from China. Comer and McClain note that the ...
The screen portrayal of a cancer sufferer whose illegal import ... drugs. For instance, Coherus BioSciences of the U.S. and Shanghai Junshi Biosciences of China in last October received U.S. FDA ...
Cancer drugs, in particular, are in such short supply that the FDA has temporarily authorized the medical industry to import non-FDA-approved drugs from China. Comer and McClain note that the ...
as most of the drugs have received FDA and EU approval, it is quite striking that China does not allow imports of drugs from India. Indian pharmaceutical companies have taken up the issue with the ...
In 2008, adulterated chemicals from a manufacturing plant for the blood-thinner heparin in China led to 81 deaths in the U.S. Ten years later, a cancer causing ... of shortages of the drug were ...
The FDA said on Wednesday that the approval allows the use of the drug to treat patients with ROS1-positive non-small cell lung cancer (NSCLC), which occurs when the ROS1 gene fuses with another ...
